Results 41 to 50 of about 21,804,485 (185)

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients

open access: yesPharmaceutics, 2022
Some years ago, excipients were considered inert substances irrelevant in the absorption process. However, years of study have demonstrated that this belief is not always true.
Isabel González-Álvarez   +6 more
doaj   +1 more source

Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling

open access: yesPharmaceutics, 2022
The development of extended-release dosage forms with adequate drug release is a challenge for pharmaceutical companies, mainly when the drug presents high solubility, as in Biopharmaceutics Classification System (BCS) class I.
Michele Georges Issa   +4 more
doaj   +1 more source

Comparative analysis of biopharmaceutic classification system (BCS) based biowaiver protocols to validate equivalence of a multisource product [PDF]

open access: yesAfrican Journal of Pharmacy and Pharmacology, 2020
Biopharmaceutic classification system (BCS) is a substantial part of drug designing and generic product development and has been accepted as a technique to renounce in-vivo pharmacokinetic evaluation (biowaiver). It appeared to be worthwhile and time-saving by means of in-vitro studies in the presence of biorelevant physiological mediums that mimic not
Khalid Farah   +6 more
openaire   +1 more source

Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System

open access: yesPharmaceutics, 2019
The objective was using the Essential Medicines List for children by the World Health Organization (WHO) to create a pediatric biopharmaceutics classification system (pBCS) of the oral drugs included in the Essential Medicines List by the World Health ...
Jose-Manuel delMoral-Sanchez   +4 more
doaj   +1 more source

Orally disintegrating tablets containing famotidine nanoparticles provide high intestinal absorbability via the energy-dependent endocytosis pathway

open access: yesFrontiers in Bioengineering and Biotechnology, 2023
The permeability of the Biopharmaceutics Classification System (BCS) class III drugs are low, and their oral bioavailability needs to be improved. In this study, we attempted to design oral formulations containing famotidine (FAM) nanoparticles to ...
Noriaki Nagai   +8 more
doaj   +1 more source

Comparative study of Two In Vitro Methods for Assessing Drug Absorption: Sartorius SM 16750 Apparatus Versus Everted Gut Sac

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2011
– Purpose. Oral drug administration remains the most common and most convenient way used in clinical therapy. The availability of a simple, rapid, economic and reproducible in vitro method to assess drug absorption is a very helpful tool.
Mohamed Ali Lassoued   +2 more
doaj   +1 more source

Solubility evaluation of didanosine: a comparison between the equilibrium method and intrinsic dissolution for biopharmaceutics classification purposes

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2017
BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) were proposed as tools for classifying drugs into four categories.
André Bersani Dezani   +3 more
doaj   +1 more source

Gliclazide: Biopharmaceutics Characteristics to Discuss the Biowaiver of Immediate and Extended Release Tablets

open access: yesApplied Sciences, 2020
The lists of essential medicines of the World Health Organization (WHO) and Brazil include gliclazide as an alternative to the oral antidiabetic drug of first choice, metformin, in the treatment of type 2 diabetes mellitus because of its pharmacokinetic ...
Bruna de Carvalho Mapa   +4 more
doaj   +1 more source

The evaluation of valsartan biopharmaceutics properties.

open access: yes, 2020
Background: Solubility, intestinal permeability and dissolution are the main factors that govern the rate and extent of drugs absorption and are directly related to bioavailability.
Souza, Jacqueline de   +15 more
core   +1 more source

State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS):New Additions, Revisions, and Citation References [PDF]

open access: yes, 2022
The Biopharmaceutics Drug Disposition Classification system (BDDCS) is a four-class approach based on water solubility and extent of metabolism/permeability rate. Based on the BDDCS class to which a drug is assigned, it is possible to predict the role of
Oprea, Tudor I   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy